Mohsen Kerkeni

Summary

Country: France

Publications

  1. doi request reprint Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients
    Mohsen Kerkeni
    Higher Institute of Biotechnology, Monastir University, Tunisia
    Diab Vasc Dis Res 10:239-45. 2013
  2. doi request reprint Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy
    Mohsen Kerkeni
    Laboratory of Biochemistry, UR Human Nutrition and Metabolic Disorders, Faculty of Medicine, Monastir University, Tunisia
    Microvasc Res 84:378-83. 2012
  3. doi request reprint Endothelial nitric oxide synthetase, methylenetetrahydrofolate reductase polymorphisms, and cardiovascular complications in Tunisian patients with nondiabetic renal disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, 5000 Monastir, Tunisia
    Clin Biochem 42:958-64. 2009
  4. doi request reprint Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, 5000 Monastir, Tunisia
    Clin Biochem 42:777-82. 2009
  5. doi request reprint Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, 5000 Monastir, Tunisia
    Ann Clin Biochem 45:193-8. 2008
  6. ncbi request reprint Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia
    Ann Clin Biochem 43:200-6. 2006
  7. ncbi request reprint Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia, and Department of Biochemistry, Hospital Saint Joseph, 75014 Paris, France
    Clin Biochem 39:821-5. 2006
  8. ncbi request reprint Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia
    Clin Chem 52:53-8. 2006
  9. ncbi request reprint Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia
    Mol Cell Biochem 291:119-26. 2006
  10. doi request reprint Apolipoprotein A-I, apolipoprotein B, high-sensitivity C-reactive protein and severity of coronary artery disease in Tunisian population
    Mohamed Yahia Hrira
    Laboratory of Biochemistry CHU Hached, Sousse, Tunisia Research Unit 07 UR 06, Faculty of Pharmacy, Monastir, Tunisia
    Cardiovasc Pathol 21:455-60. 2012

Collaborators

Detail Information

Publications10

  1. doi request reprint Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients
    Mohsen Kerkeni
    Higher Institute of Biotechnology, Monastir University, Tunisia
    Diab Vasc Dis Res 10:239-45. 2013
    ..004) and the presence of hypertension (p = 0.018) and hyperlipidaemia (p = 0.036). Pentosidine levels may be a biomarker for microvascular complications in type 2 diabetic patients...
  2. doi request reprint Elevated serum levels of AGEs, sRAGE, and pentosidine in Tunisian patients with severity of diabetic retinopathy
    Mohsen Kerkeni
    Laboratory of Biochemistry, UR Human Nutrition and Metabolic Disorders, Faculty of Medicine, Monastir University, Tunisia
    Microvasc Res 84:378-83. 2012
    ..We measured serum AGE, sRAGE and pentosidine levels in Tunisian patients with diabetic retinopathy (DR) and examined whether these biomarkers are related to the severity of DR...
  3. doi request reprint Endothelial nitric oxide synthetase, methylenetetrahydrofolate reductase polymorphisms, and cardiovascular complications in Tunisian patients with nondiabetic renal disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, 5000 Monastir, Tunisia
    Clin Biochem 42:958-64. 2009
    ..We investigated (a) the relationship of these gene polymorphisms with the presence and the severity of renal disease, and (b) their relationships with CVD in these patients...
  4. doi request reprint Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, 5000 Monastir, Tunisia
    Clin Biochem 42:777-82. 2009
    ..We determine homocysteine levels (Hcy), paraoxonase (PON1) concentration and their relationship on cardiovascular complications in patients with chronic renal disease (CRD)...
  5. doi request reprint Hyperhomocysteinaemia and parameters of antioxidative defence in Tunisian patients with coronary heart disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, 5000 Monastir, Tunisia
    Ann Clin Biochem 45:193-8. 2008
    ..The aim of this study was to test the parameters of antioxidative defence and to assess their association with hyperhomocysteinaemia and the severity of coronary heart disease (CHD) in Tunisian patients...
  6. ncbi request reprint Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia
    Ann Clin Biochem 43:200-6. 2006
    ..The methylenetetrahydrofolate reductase (MTHFR) polymorphism is associated with hyperhomcysteinaemia and may therefore influence individual susceptibility to CAD. We have investigated this risk factor in a Tunisian Arab population...
  7. ncbi request reprint Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia, and Department of Biochemistry, Hospital Saint Joseph, 75014 Paris, France
    Clin Biochem 39:821-5. 2006
    ..We investigated (a) PON1 activity and polymorphisms, and (b) the relationship between PON1 activity, homocysteine (Hcy) and the severity of CAD patients in Tunisian population...
  8. ncbi request reprint Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia
    Clin Chem 52:53-8. 2006
    ....
  9. ncbi request reprint Comparative study on in vitro effects of homocysteine thiolactone and homocysteine on HUVEC cells: evidence for a stronger proapoptotic and proinflammative homocysteine thiolactone
    Mohsen Kerkeni
    Research Unit 03 UR 08 14, Faculty of Pharmacy, Monastir, Tunisia
    Mol Cell Biochem 291:119-26. 2006
    ..This study suggests that Homocysteine derivatives like HcyT might possess stronger cytotoxicity and pro-inflammatory properties and that Hcy derivatives levels should therefore be more taken into account during diagnostics...
  10. doi request reprint Apolipoprotein A-I, apolipoprotein B, high-sensitivity C-reactive protein and severity of coronary artery disease in Tunisian population
    Mohamed Yahia Hrira
    Laboratory of Biochemistry CHU Hached, Sousse, Tunisia Research Unit 07 UR 06, Faculty of Pharmacy, Monastir, Tunisia
    Cardiovasc Pathol 21:455-60. 2012
    ..We investigated the association between serum ApoA-I, ApoB, hs-CRP and the severity of coronary artery disease...